UY26179A1 - Amidas sustituidas del ácido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporación de adenosina. - Google Patents
Amidas sustituidas del ácido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporación de adenosina.Info
- Publication number
- UY26179A1 UY26179A1 UY26179A UY26179A UY26179A1 UY 26179 A1 UY26179 A1 UY 26179A1 UY 26179 A UY26179 A UY 26179A UY 26179 A UY26179 A UY 26179A UY 26179 A1 UY26179 A1 UY 26179A1
- Authority
- UY
- Uruguay
- Prior art keywords
- acid
- phenylclohexanocarboxylic
- substituted amides
- adenosine
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a amidas sustituídas del ácido fenilciclohexanocarboxílico de fórmula (I), a procedimientos para su obtención y a su uso en medicamentos, especialmente para el tratamiento de enfermedades cardiovasculares.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19924819A DE19924819A1 (de) | 1999-05-29 | 1999-05-29 | Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren) |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26179A1 true UY26179A1 (es) | 2000-12-29 |
Family
ID=7909713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26179A UY26179A1 (es) | 1999-05-29 | 2000-05-29 | Amidas sustituidas del ácido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporación de adenosina. |
Country Status (25)
Country | Link |
---|---|
US (1) | US6984642B1 (es) |
EP (1) | EP1187812B1 (es) |
JP (1) | JP2003500474A (es) |
KR (1) | KR20020000814A (es) |
CN (1) | CN1165526C (es) |
AR (1) | AR029639A1 (es) |
AT (1) | ATE303995T1 (es) |
AU (1) | AU766140B2 (es) |
BR (1) | BR0011049A (es) |
CA (1) | CA2375188A1 (es) |
CO (1) | CO5170503A1 (es) |
DE (2) | DE19924819A1 (es) |
DK (1) | DK1187812T3 (es) |
ES (1) | ES2248071T3 (es) |
GT (1) | GT200000085A (es) |
HK (1) | HK1047107B (es) |
HN (1) | HN2000000078A (es) |
IL (1) | IL146231A0 (es) |
MX (1) | MXPA01012240A (es) |
PE (1) | PE20010132A1 (es) |
PL (1) | PL365960A1 (es) |
TR (1) | TR200103398T2 (es) |
UY (1) | UY26179A1 (es) |
WO (1) | WO2000073274A2 (es) |
ZA (1) | ZA200108894B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10150310A1 (de) * | 2001-10-11 | 2003-04-24 | Bayer Ag | Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung |
KR100762857B1 (ko) * | 2005-03-07 | 2007-10-02 | 김기완 | Pe시트를 이용한 저수조의 방수 공법 |
KR100762858B1 (ko) * | 2005-03-07 | 2007-10-02 | 김기완 | Pe시트를 이용한 저수조의 방수 공법 |
KR100745024B1 (ko) * | 2005-05-09 | 2007-08-01 | 김준 | 거푸집 수평조절장치 |
US8507559B2 (en) * | 2008-07-16 | 2013-08-13 | Bristol-Myers Squibb Company | Cyclohexenyl modulators of chemokine receptor activity |
EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0582164B1 (en) * | 1992-07-31 | 1998-12-23 | Bristol-Myers Squibb Company | Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
DE4304455A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate |
DE19503160A1 (de) * | 1995-02-01 | 1996-08-08 | Bayer Ag | Verwendung von Phenylcyclohexylcarbonsäureamiden |
US6015774A (en) * | 1995-09-22 | 2000-01-18 | Sumitomo Chemical Company, Limited | Pyrazin-2-one derivatives, their use, and intermediates for their production |
US5723313A (en) * | 1995-09-27 | 1998-03-03 | St. Jude Children's Research Hospital | ARF-p19, a novel regulator of the mammalian cell cycle |
-
1999
- 1999-05-29 DE DE19924819A patent/DE19924819A1/de not_active Withdrawn
-
2000
- 2000-05-16 PL PL00365960A patent/PL365960A1/xx not_active Application Discontinuation
- 2000-05-16 KR KR1020017015253A patent/KR20020000814A/ko not_active Application Discontinuation
- 2000-05-16 AT AT00925290T patent/ATE303995T1/de not_active IP Right Cessation
- 2000-05-16 TR TR2001/03398T patent/TR200103398T2/xx unknown
- 2000-05-16 CN CNB008082170A patent/CN1165526C/zh not_active Expired - Fee Related
- 2000-05-16 WO PCT/EP2000/004431 patent/WO2000073274A2/de not_active Application Discontinuation
- 2000-05-16 MX MXPA01012240A patent/MXPA01012240A/es active IP Right Grant
- 2000-05-16 CA CA002375188A patent/CA2375188A1/en not_active Abandoned
- 2000-05-16 AU AU44057/00A patent/AU766140B2/en not_active Ceased
- 2000-05-16 DK DK00925290T patent/DK1187812T3/da active
- 2000-05-16 EP EP00925290A patent/EP1187812B1/de not_active Expired - Lifetime
- 2000-05-16 US US09/980,242 patent/US6984642B1/en not_active Expired - Fee Related
- 2000-05-16 DE DE50011122T patent/DE50011122D1/de not_active Expired - Fee Related
- 2000-05-16 JP JP2000621340A patent/JP2003500474A/ja active Pending
- 2000-05-16 BR BR0011049-3A patent/BR0011049A/pt not_active IP Right Cessation
- 2000-05-16 ES ES00925290T patent/ES2248071T3/es not_active Expired - Lifetime
- 2000-05-16 IL IL14623100A patent/IL146231A0/xx unknown
- 2000-05-17 HN HN2000000078A patent/HN2000000078A/es unknown
- 2000-05-24 CO CO00038312A patent/CO5170503A1/es not_active Application Discontinuation
- 2000-05-26 PE PE2000000505A patent/PE20010132A1/es not_active Application Discontinuation
- 2000-05-26 GT GT200000085A patent/GT200000085A/es unknown
- 2000-05-29 AR ARP000102649A patent/AR029639A1/es not_active Application Discontinuation
- 2000-05-29 UY UY26179A patent/UY26179A1/es not_active Application Discontinuation
-
2001
- 2001-10-29 ZA ZA200108894A patent/ZA200108894B/xx unknown
-
2002
- 2002-12-04 HK HK02108818.1A patent/HK1047107B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1165526C (zh) | 2004-09-08 |
US6984642B1 (en) | 2006-01-10 |
IL146231A0 (en) | 2002-07-25 |
MXPA01012240A (es) | 2002-08-12 |
DE50011122D1 (de) | 2005-10-13 |
BR0011049A (pt) | 2002-03-19 |
CA2375188A1 (en) | 2000-12-07 |
HK1047107B (zh) | 2005-05-20 |
WO2000073274A2 (de) | 2000-12-07 |
AR029639A1 (es) | 2003-07-10 |
ZA200108894B (en) | 2003-01-29 |
JP2003500474A (ja) | 2003-01-07 |
ES2248071T3 (es) | 2006-03-16 |
EP1187812B1 (de) | 2005-09-07 |
TR200103398T2 (tr) | 2002-03-21 |
GT200000085A (es) | 2001-11-17 |
EP1187812A2 (de) | 2002-03-20 |
DE19924819A1 (de) | 2000-11-30 |
DK1187812T3 (da) | 2005-12-12 |
CO5170503A1 (es) | 2002-06-27 |
PL365960A1 (en) | 2005-01-24 |
KR20020000814A (ko) | 2002-01-05 |
AU766140B2 (en) | 2003-10-09 |
WO2000073274A3 (de) | 2001-04-19 |
HK1047107A1 (en) | 2003-02-07 |
CN1353693A (zh) | 2002-06-12 |
HN2000000078A (es) | 2001-02-02 |
AU4405700A (en) | 2000-12-18 |
PE20010132A1 (es) | 2001-04-12 |
ATE303995T1 (de) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP056019A (es) | 2,4-di(fenilamino)pirimidinas útiles en el tratamiento de enfermedades neoplásicas, trastornos inflamatorios y del sistema inmune | |
BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
SV1999000047A (es) | Nuevas dihidropirimidinas fef. lea 32792-sv | |
CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
CR10192A (es) | Compuestos de amido y su uso como productos farmaceuticos | |
HK1075450A1 (en) | heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine | |
UY26133A1 (es) | Derivado sustituido de pirazol. | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
TW200621703A (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
ECSP088472A (es) | Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento | |
DOP2003000621A (es) | Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa | |
UY28115A1 (es) | Derivados del acido isoftalico | |
BRPI0509667A (pt) | azaquinazolinas substituìdas com eficácia antiviral | |
UY26179A1 (es) | Amidas sustituidas del ácido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporación de adenosina. | |
UA95780C2 (en) | Xanthine derivatives as selective hm74a agonists | |
UY27733A1 (es) | Derivados de ciclopenteno. | |
ECSP003501A (es) | Amidas sustituidas del acido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporacion de adenosina | |
DK1904511T3 (da) | Homogemcitabin | |
UY26930A1 (es) | Amidas de ácido fenilciclohexanocarboxílico sustituido y su uso | |
ECSP045210A (es) | 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco | |
ATE553088T1 (de) | Substituierte chinolone ii | |
MX2007013306A (es) | Nuevas tiazolidinonas sin nitrogeno basico, su produccion y su uso como agentes farmaceuticos. | |
PA8579401A1 (es) | Derivados de 2,3-dihidro-isoindol-1-ona como inhibidores de mao-b | |
UY27475A1 (es) | Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización | |
GB0229022D0 (en) | Organic Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20110715 |